| Literature DB >> 33614947 |
Abstract
In the evolving field of medicinal cannabis, there are many questions and concerns broached by patients to which health care providers cannot respond with anything other than anecdotal evidence. Many simple knowledge gaps persist due to barriers to high-quality research at the institutional and state levels: barriers that, in turn, stem from the federal designation of cannabis as an illegal substance. These perspectives of a California-based pain physician on the approach to the cannabis-curious pain patient highlight the necessity of a change in the classification of cannabis to streamline research as to the benefits and risks of this now ubiquitous substance. Copyright 2021, Mary Ann Liebert, Inc., publishers.Entities:
Keywords: cannabinoid analgesia; drug abuse; medical marijuana; opioids; pain; public policy
Mesh:
Substances:
Year: 2021 PMID: 33614947 PMCID: PMC7891198 DOI: 10.1089/can.2020.0030
Source DB: PubMed Journal: Cannabis Cannabinoid Res ISSN: 2378-8763